Understanding Chronic Treatments by Patients Over 65 Years of Age

NCT ID: NCT07241299

Last Updated: 2025-11-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-11-17

Study Completion Date

2026-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65.

This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance.

One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objectives Primary: To describe the understanding of chronic treatments by patients over 65 years of age.

Secondary: To investigate the factors associated with the understanding of chronic treatments by patients over 65 years of age.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Treatments

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

data collection

Data collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are aged 65 or over
* Consulting one of the general practitioners agreeing to participate in the study
* Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
* Agree to participate in the study.

Exclusion Criteria

* Does not understand French,
* Has neurocognitive disorders
* Lives in a medical facility
* Consulting for an acute condition and whose prescription does not include chronic treatment.
* Protected by law (guardianship, curatorship, judicial protection),
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Reims Champagne-Ardenne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gestonnairedu CURRS

Reims, Université de Reims Champagne-Ardenne, France

Site Status RECRUITING

Ufr Medecine Urca

Reims, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gestonnairedu CURRS

Role: CONTACT

0326918822 ext. 0033

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gestonnairedu CURRS

Role: primary

0326918822

Coralie Barbe

Role: primary

326913665 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025_RIPH_02_ordonnance

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Polypharmacy Among Internal Medicine Patients
NCT05756400 ACTIVE_NOT_RECRUITING